PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2014.46.3.2882014463288-296Impact of Hyperglycemia on Survival and Infection-Related Adverse Events in Patients with Metastatic Colorectal Cancer Who Were Receiving Palliative ChemotherapyYong Joo Hong, Hye-Suk Han, Yusook Jeong, Jiwon Jeong, Sung-Nam Lim, Hyung Jin Choi, Hyun-Jung Jeon, Tae-Keun Oh, Sang-Jeon Lee, Ki Hyeong Leehttp://www.e-crt.org/upload/pdf/crt-46-3-288.pdf, http://www.e-crt.org/upload/pdf/crt-46-3-288.pdf
10.21203/rs.3.rs-120045/v12020Relationship between adverse events of adjuvant chemotherapy and survival outcomes: mediation analysis of Chinese colorectal cancer patientsChang Geng, Yuanren Tong, Na Zhou, Yingyi Wanghttps://www.researchsquare.com/article/rs-120045/v1, https://www.researchsquare.com/article/rs-120045/v1.html
Cancer Treatment Reviews10.1016/j.ctrv.2004.09.0032004308715-720Bevacizumab in combination with irinotecan plus fluorouracil plus leucovorin chemotherapy prolongs survival but increases adverse events in people with metastatic colorectal cancerMichael A. Chotihttps://api.elsevier.com/content/article/PII:S0305737204001495?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0305737204001495?httpAccept=text/plain
Clinical Colorectal Cancer10.1016/j.clcc.2012.12.001201312286-94Adverse Events Associated With Antiangiogenic Agents in Combination With Cytotoxic Chemotherapy in Metastatic Colorectal Cancer and Their ManagementThomas H. Cartwrighthttps://api.elsevier.com/content/article/PII:S1533002813000224?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1533002813000224?httpAccept=text/plain
Value in Health10.1016/j.jval.2011.02.9582011143A173PCN104 HOSPITAL COSTS OF ADVERSE EVENTS IN PATIENTS RECEIVING TREATMENT FOR METASTATIC COLORECTAL CANCERA.Z. Fu, Z. Zhao, S. Wang, S. Gao, B. Barber, G. Liuhttps://api.elsevier.com/content/article/PII:S1098301511010977?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1098301511010977?httpAccept=text/plain
Colorectal Disease10.1111/j.1463-1318.2011.02817.x2012148920-930Palliative excisional surgery for primary colorectal cancer in patients with incurable metastatic disease. Is there a survival benefit? A systematic reviewS. Anwar, M. B. Peter, J. Dent, N. A. Scotthttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1463-1318.2011.02817.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1463-1318.2011.02817.x/fullpdf
Clinical Colorectal Cancer10.1016/j.clcc.2012.11.0042013123204-213.e1Adverse Events Associated With Bevacizumab and Chemotherapy in Older Patients With Metastatic Colorectal CancerVeena Shankaran, David Mummy, Lisel Koepl, David Blough, Yeun Mi Yim, Elaine Yu, Scott Ramseyhttps://api.elsevier.com/content/article/PII:S1533002812001454?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1533002812001454?httpAccept=text/plain
Clinical Colorectal Cancer10.1016/j.clcc.2018.12.0062019182110-115.e2Impact of Sex on Chemotherapy Toxicity and Efficacy Among Patients With Metastatic Colorectal Cancer: Pooled Analysis of 5 Randomized TrialsOmar Abdel-Rahmanhttps://api.elsevier.com/content/article/PII:S1533002818305668?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1533002818305668?httpAccept=text/plain
Lung Cancer10.1016/s0169-5002(08)70073-4200860S23Assessment of lung cancer related symptoms and treatment related side effects in a group of patients with advanced lung cancer receiving palliative chemotherapyE. Mannion, D. Waldron, J.J. Gilmartinhttps://api.elsevier.com/content/article/PII:S0169500208700734?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500208700734?httpAccept=text/plain
ANZ Journal of Surgery10.1111/ans.1472620188811E772-E777Modern-day palliative chemotherapy for metastatic colorectal cancer: does colonic resection affect survival?Joel Wen Liang Lau, Heidi Sian Ying Chang, Kai Yin Lee, Yong Xiang Gwee, Wen Qiang Lee, Choon Seng Chonghttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fans.14726, http://onlinelibrary.wiley.com/wol1/doi/10.1111/ans.14726/fullpdf